Picture of Biocure Technology logo

CURE Biocure Technology Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
EnergyHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for Biocure Technology, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:9 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-4.78-6.59-4.79-3.08-1.15
Depreciation
Non-Cash Items2.963.371.67-0.09-1.73
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.0910.5750.391.81.72
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-1.88-2.59-2.68-1.31-1.08
Capital Expenditures-0.409-0.0410-0.003-0.004
Purchase of Fixed Assets
Other Investing Cash Flow Items-0.022-0.932-1.050.094
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-0.431-0.973-1.050.091-0.004
Financing Cash Flow Items0.0040.40
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2.652.63.691.131.17
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.225-0.9750.024-0.0860.112

Or unlock with your email

Or unlock with your email